The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | CAR-T: driving the field
Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses, new developments in the field of CAR T-cell therapy for leukemias and lymphomas and touches on upcoming products on the horizon. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
